Elcelyx Therapeutics' Series D Round

Elcelyx Therapeutics raised a round of funding on February 21, 2014.

Elcelyx Therapeutics is developing therapeutic agents based on the finding that modulation of the neuro-enteroendocrine system of the gut, including L-cells, amplifies the release of hormones such as …

Articles about Elcelyx Therapeutics' Series D Round: